Sign in to baba News

One account across the web, iPhone and Android — your subscription follows it.

or use an email code

By continuing you agree to the terms and privacy policy.

Welcome — one more step

News Plus opens the cross-newsroom layer — who covered a story, who didn’t, and how each one worded it.

  • Unlimited follows
  • Alerts for what you follow (in the app)
  • Story alerts (in the app)
  • Hide read stories (in the app)
  • The daily brief by email
  • Headlines side by side
  • Who reported first
  • The whole archive
  • Your reading diet
  • Duki without the monthly limit

Eligible new subscribers get 7 days free, then $34.99 each year. Renews automatically until cancelled. Cancel any time in your account. Subscription terms.

Your subscription also unlocks the app.

Download on theApp StoreGet it onGoogle Play

Search stories

Type at least two characters. Results come from every newsroom baba reads.

↑↓ to move · ↵ to open · esc to close

Live Terminal
Health · Full coverage

Novo Nordisk Trial Shows Promising Weight Loss Results for Children Aged 6-12

How 2 Israeli newsrooms covered this story — translated into English and compared side by side.

Unrated 2

By كل العرب

First reported by Panet · 9 hours ago

What happened

Novo Nordisk's preliminary trial results show 40% of children aged 6-12 treated with semaglutide were no longer obese after 68 weeks. The drug is not yet approved for this age group, but its use is increasing, prompting further safety and efficacy studies.

  • 01Semaglutide trial shows 40% of children aged 6-12 no longer obese.
  • 02Drug is not approved for children under 12, but prescriptions are rising.
  • 03Safety profile consistent with adults; no new concerns found.
  • 04Study included lifestyle changes alongside medication.
  • 05US study shows a 310-fold increase in prescriptions for 8-11 year olds.

Summary translated & synthesized from the sources below by baba. Read each original for the full report.

In this story
People
OrganizationsNovo Nordisk, NYU Langone Health
PlacesUnited States, Israel

Full coverage · 2 outlets

The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.

AlarabUnrated · Arabic5 hours ago
Novo Nordisk Trial Shows Promising Weight Loss Results for Children Aged 6-12
PanetUnrated · Arabic9 hours ago
Weight-Loss Drug Shows Promise in Young Children, Trial Results Indicate

Related stories

Obesity Drug Shows Promising Results in Young Children StudySep 7, 2026Wegovy Trial Shows Significant Weight Loss in Children Aged 6-12Sep 7, 2026New Study Suggests Weight-Loss Drug Semaglutide May Slow Biological AgingJul 26, 2026Novo Nordisk Partners with Vivani Medical to Improve Obesity Drug Adherence with Biannual ImplantJul 14, 2026Semaglutide Linked to Lower Psychiatric Hospitalization Risk in Bipolar Disorder StudySep 12, 2026US Study Reveals Alarming 310-Fold Rise in Obesity Drug Prescriptions for Young ChildrenSep 6, 2026